Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002023658-25-000085
Filing Date
2025-06-18
Accepted
2025-06-18 17:12:19
Documents
1
Period of Report
2025-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750281133.html 4  
1 FORM 4 wk-form4_1750281133.xml 4 9701
  Complete submission text file 0002023658-25-000085.txt   11138
Mailing Address C/O VIRIDIAN THERAPEUTICS, INC. 203 CRESCENT STREET, BLDG. 17, SUITE 102 WALTHAM MA 02453
Business Address
Meisner Lara (Reporting) CIK: 0001883986 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 251057824

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)